People: Novogen Ltd (NVGN.O)

Mr. David Seaton, Chief Financial Officer of Novogen Ltd., has been appointed as Acting Chief Executive Officer. Mr. Seaton is a graduate in Business Studies holds a Master of Commerce degree from the University of New South Wales. He has completed Management Development programs at Northwestern University in Chicago, Illinois, Duke University in Durham, North Carolina and the London Business School. He has had 20 years experience in the pharmaceutical industry and prior to joining Novogen Limited in 1999 was the Finance Director of GlaxoWellcome Australia Ltd. Mr. Seaton was also Finance Director of Wellcome Australia Limited prior to its merger with Glaxo in 1995. Mr. Seaton has been the Chief Financial Officer and Secretary of Marshall Edwards since 2000. He has been a Director and the Secretary of Glycotex, Inc since September 2005. Mr. Seaton was appointed Chief Financial Officer of Glycotex, Inc. in November 2006.